KD Logo

Mersana Therapeutics Inc [MRSN] Records 200-Day SMA of $2.7343

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mersana Therapeutics Inc shares valued at $79,671 were sold by Protopapas Anna on Jan 16 ’24. At $2.71 per share, Protopapas Anna sold 29,399 shares. The insider’s holdings dropped to 125,153 shares worth approximately $0.25 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Lowinger Timothy B sold 10,409 shares, netting a total of over 28,208 in proceeds. Following the sale of shares at $2.71 each, the insider now holds 199,329 shares.

Before that, DeSchuytner Brian had sold 9,327 shares from its account. In a trade valued at $25,276, the SVP, COO & CFO traded Mersana Therapeutics Inc shares for $2.71 each. Upon closing the transaction, the insider’s holdings decreased to 9,327 shares, worth approximately $0.11 million.

As published in a research note from JP Morgan on March 19, 2024, Mersana Therapeutics Inc [MRSN] has been rated up from an Underweight to a Neutral and the price target has been revised to $5. Analysts at Wedbush upgraded the stock from ‘”a Neutral”‘ to ‘”an Outperform”‘ outlook in a report released in late February. As of February 29, 2024, Guggenheim has increased its “Neutral” rating to a “Buy” for MRSN. Earlier on February 29, 2024, BTIG Research upgraded its rating. Their new recommendation was “a Buy” for MRSN stock which previously was a “a Neutral”.

Analyzing MRSN Stock Performance

During the last five days, there has been a surge of approximately 5.38%. Over the course of the year, Mersana Therapeutics Inc shares have dropped approximately -15.52%. Shares of the company reached a 52-week high of $6.2801 on 03/11/24 and a 52-week low of $1.7600 on 07/05/24. A 50-day SMA is recorded $2.4323, while a 200-day SMA reached $2.7343. Nevertheless, trading volume fell to 0.55 million shares from 1.28 million shares the previous day.

Support And Resistance Levels for Mersana Therapeutics Inc (MRSN)

According to the 24-hour chart, there is a support level at 1.9133, which, if violated, would cause prices to drop to 1.8667. In the upper region, resistance lies at 1.9933. The next price resistance is at 2.0267. RSI (Relative Strength Index) is 38.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0658, which suggests the price will decrease in the coming days. Percent R is at 59.18%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular